These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 14993430)

  • 1. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM
    Mol Interv; 2003 Mar; 3(2):90-105, 51. PubMed ID: 14993430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical drug targeting to the brain.
    Pardridge WM
    J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ; de Boer AG
    Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the brain--surmounting or bypassing the blood-brain barrier.
    Potschka H
    Handb Exp Pharmacol; 2010; (197):411-31. PubMed ID: 20217538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Curr Opin Pharmacol; 2006 Oct; 6(5):494-500. PubMed ID: 16839816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y; Liu L
    Adv Drug Deliv Rev; 2012 May; 64(7):640-65. PubMed ID: 22154620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for effective brain drug delivery.
    Alam MI; Beg S; Samad A; Baboota S; Kohli K; Ali J; Ahuja A; Akbar M
    Eur J Pharm Sci; 2010 Aug; 40(5):385-403. PubMed ID: 20497904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of therapeutic molecules into the CNS.
    Emborg ME; Kordower JH
    Prog Brain Res; 2000; 128():323-32. PubMed ID: 11105691
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD; Geldenhuys WJ
    Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.